Immuneering Corporation (IMRX) Net Margin
- 2022-12-31: Net Margin -2911112.31%.
- 2022-09-30: Net Margin -33466.21%.
- 2022-06-30: Net Margin -12208.67%.
- 2022-03-31: Net Margin -7020.42%.
Complete source-backed net margin history.
- Available history
- 2020-06-30 to 2022-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2022-12-31 | -2911112.31% |
| 2022-09-30 | -33466.21% |
| 2022-06-30 | -12208.67% |
| 2022-03-31 | -7020.42% |
| 2021-12-31 | -5688.22% |
| 2021-09-30 | -1770.08% |
| 2021-06-30 | -1210.18% |
| 2021-03-31 | -832.62% |
| 2020-12-31 | -877.48% |
| 2020-09-30 | -644.49% |
| 2020-06-30 | -749.56% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2022-12-31 | -15937.29% |
| 2021-12-31 | -1612.33% |
| 2020-12-31 | -737.17% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |